ahlam1399
01-20-2017, 08:11 PM
BRIEF-Additional data analyses from phase IIb trial of MIN-101 in schizophrenia underscore benefit in multiple measurements of cognitive function
* Additional data analyses from phase IIb trial of MIN-101 in schizophrenia underscore benefit in multiple measurements of cognitive function Source text for Eikon: Further company coverage: http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=2c_X4lhILK0:i2tRxVL-yGw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=2c_X4lhILK0:i2tRxVL-yGw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=2c_X4lhILK0:i2tRxVL-yGw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=2c_X4lhILK0:i2tRxVL-yGw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=2c_X4lhILK0:i2tRxVL-yGw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/2c_X4lhILK0
* Additional data analyses from phase IIb trial of MIN-101 in schizophrenia underscore benefit in multiple measurements of cognitive function Source text for Eikon: Further company coverage: http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=2c_X4lhILK0:i2tRxVL-yGw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=2c_X4lhILK0:i2tRxVL-yGw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=2c_X4lhILK0:i2tRxVL-yGw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=2c_X4lhILK0:i2tRxVL-yGw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=2c_X4lhILK0:i2tRxVL-yGw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/2c_X4lhILK0